Mesothelioma
Advertisement
A distributed clinical trial is analyzing diet and exercise patterns in young people with lung cancer.
Christopher Seder, MD, discusses the database and how it can be used for research, quality improvement, and risk ...
The initiative aims to increase biomarker testing rates in communities most impacted by lung cancer disparities.
The foundation's 2024 Scientific Grant Program awards mark the "largest single-year investment in its history.”
Researchers conducted an extensive analysis of PM2.5 exposure based on residential history, satellite data, and more.
Arthi Sridhar, MD, discusses the real-world study, which was presented at the IASLC 2024 World Conference on Lung Cancer.
Learn what the global survey showed about the rates of biomarker testing and the remaining barriers to implementation.
Michael R. Gieske, MD, discusses the lung cancer screening initiative, which has been recognized on a national level.
The registry, launched by the Florez Lab in 2023, is collecting data from around the world.
Indoor air pollutants can come from multiple sources and can be risk factors for developing lung cancer.
Shirish M. Gadgeel, MD, shares how treatment options and patient outcomes have evolved since he began practicing.
Dr. Gieske shares what the White Ribbon Project means to him as a lung cancer clinician.
Annette McWilliams, MBBS, FRACP, PhD, discusses her IASLC Presidential Symposium presentation on the study.
Jamie L. Studts, PhD, discusses the use of the QUILS™ system in Kentucky and the importance of community engagement.
The KEYNOTE-483 trial showed a significant improvement in OS with the addition of pembrolizumab to chemotherapy.
Martin Reck, MD, PhD, shares his insights on key data in lung cancer to be presented at the ESMO Congress 2024.
Narjust Florez, MD, FASCO, discusses meeting highlights, the IASLC 50th Anniversary Celebration, research, and more.
Researchers used data from the Thoracic Tumors Registry to conduct 2 analyses using artificial intelligence.
Eric Singhi, MD, discusses the key milestone that will be celebrated at the conference, which will be held in San Diego.
The study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in lung cancer.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.